Precision Medical Products — Stock, Pipeline & Market Cap

Is this your company? Claim your profile to update info and connect with investors.

Private Company

Funding information not available

Overview

Precision Medical Products is a privately-held medical device company pioneering mobile, tubeless, and cordless DVT prevention systems. Its flagship products, VenaOne® for acute care and Circul8 Pro® for at-home use, form a continuum-of-care platform designed to reduce patient fall risk, speed discharge, and lower healthcare costs. The company positions itself as a leader in reinventing mobile compression therapy, targeting protocol changes in hospitals and capitalizing on the shift towards value-based care and outpatient recovery. With a focus on patient safety and operational efficiency, it serves hundreds of acute care facilities across the United States.

Deep Vein Thrombosis (DVT) PreventionPost-Surgical Recovery

Technology Platform

Patented mobile, cordless, and tubeless pneumatic compression devices with extended battery life and connected data capabilities for DVT prevention and post-surgical recovery.

Opportunities

The shift to outpatient surgery and value-based care creates strong demand for solutions that enable safe, early discharge and prevent costly readmissions.

PMP's mobile, hospital-to-home platform is uniquely positioned to capitalize on this trend.

Furthermore, the growing focus on eliminating 'Never Events' like patient falls and hospital-acquired DVTs aligns perfectly with the company's core value proposition to healthcare administrators.

Risk Factors

Large, established medical device competitors could develop similar cordless devices, leveraging their extensive sales networks and existing customer contracts.

Additionally, widespread adoption requires convincing hospital value analysis committees to change protocols based on clinical and economic evidence, which can be a slow and challenging process.

Competitive Landscape

PMP competes against traditional sequential compression device (SCD) manufacturers like Zimmer Biomet (Game Ready), Arjo, and Cardinal Health, which offer tethered, bedside systems. Its primary differentiation is cordless mobility. It also faces indirect competition from pharmacological anticoagulants. PMP's strategy is to displace older SCDs by offering a superior user experience and safety profile, positioning itself as a disruptor in a mature market segment.

More companies in Digital Health & Biotech SaaS →More companies in United States →